SANOFI € 91,55 | Euronext Live Kurse

24/04/2025	Communiqué de presse : Sanofi : forte performance au T1 et confirmation des perspectives pour 202...
24/04/2025	Press Release: Sanofi: strong Q1 performance and 2025 guidance confirmed
18/04/2025	Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for...
18/04/2025	Communiqué de presse : Le Dupixent devient le premier nouveau médicament ciblé approuvé aux États...
15/04/2025	Press Release: Sanofi’s respiratory pipeline advances with new data in asthma and plans for new c...

16/04/2025

Laden... Bitte warten